Objective: The aim of this study was to examine the impact of seizures on persons living with epilepsy in a national, community-based setting. Methods: The data source was the Survey of Living with Neurological Conditions in Canada (SLNCC), a cohort derived from a national population-based survey of noninstitutionalized persons aged 15 or more years. Participants had to be on a seizure drug or to have had a seizure in the past 5 years to meet the definition of active epilepsy. The respondents were further stratified by seizure status: the seizure group experienced ≥1 seizure in the past 5 years versus the no seizure group who were seizure-free in the past ≥5 years regardless of medication status. Weighted overall and stratified prevalence estimates and odds ratios were used to estimate associations. Results: The SLNCC included 713 persons with epilepsy with a mean age of 45.4 (standard deviation 18.0) years. Fewer people in the seizure group (42.7%) reported being much better than a year ago versus those in the no seizure group (70.1%). Of those with seizures, 32.1% (95% confidence interval [95% CI] 18.8-45.3) had symptoms suggestive of major depression (as per the Patient Health Questionnaire-9) compared to 7.7% (95% CI 3.4-11.9) of those without seizures. Driving, educational, and work opportunities were also significantly limited, whereas stigma was significantly greater in those with seizures. Significance: This community-based study emphasizes the need for seizure freedom to improve clinical and psychosocial outcomes in persons with epilepsy. Seizure freedom has an important influence on overall health, as those with at least one seizure over the prior 5 years had an increased risk of mood disorders, worse quality of life, and faced significantly more stigma.
pathophysiology that predisposes to additional comorbidities. 6 In addition, the simple diagnosis alone portends negative impact on employability, personal relationships, and independent living. 7 The degree to which seizures contribute to particular clinical, psychological, and social outcomes of patients with self-reported epilepsy has not been explored extensively at a community-based level on a national scale. 12 Such an evaluation is critical to understanding the impact of the disease on a broad, population-based sample of patients with epilepsy. This is particularly pertinent given that selected clinical cohorts from ambulatory care centers, although typically enriched with more detailed information, are prone to inherent methodologic biases that can preclude external validity.
National community-based data sources, in particular, may permit advances in public health that lead to improved knowledge-to-action initiatives that are not feasible with data derived from smaller, more discrete, hospital-based series. 13 Ultimately, these data will permit insight into how the seizures themselves may influence specific outcomes in a general population of people with epilepsy. Thus the purpose of this study was to use nationally collected community level data to examine the presumed additional burden imposed by seizures on a variety of physical and psychosocial outcomes in patients with self-reported epilepsy.
Methods

Data source
The Survey of Living with a Neurological Condition in Canada (SLNCC) 14 is a cross-sectional study that adopted a sampling strategy linked to a large general populationbased health survey called the Canadian Community Health Survey (CCHS). 15 The CCHS selects a probability sample of approximately 70,000 household residents annually, who are representative of the Canadian population. The 2010 and 2011 CCHS included chronic neurologic conditions in their questionnaire and inquired whether the selected CCHS respondent, or any other person in the household, had been diagnosed by a health professional with one of 18 neurologic conditions of interest. Participants with affirmative responses were invited to participate in the SLNCC. In the event that more than one household member had a neurologic condition, only one individual over the age of 15 was selected for participation in the SLNCC. Exclusions included living in the three territories, living on an aboriginal reserve or settlement, being a full-time member of the Canadian Armed Forces, living in certain remote regions (R egion du Nunavik and R egion des Terres-Cries-de-la-Baie-James), and residing in an institution. In total, these exclusions apply to approximately 3% of the Canadian population 15 years of age and over in the 10 provinces. Data collection for the SLNCC was conducted using computer-assisted telephone interviewing (CATI) from September to October 2011, and February to March 2012, including a total of 8,222 individuals with neurologic conditions. The estimated response rate for the 2011 SLNCC was 81.6% (rounded N = 4,400 with a neurologic condition of interest).
14 Random rounding up or down to a multiple of "5" or "10" is required by Statistics Canada reporting in order to ensure confidentiality. The algorithm employed automatically rounds the units of interest to a "0" or "5" based on a predetermined frequency using a random seed value.
Epilepsy-specific variables
SLNCC respondents who reported having a doctor or health professional diagnosis of epilepsy were selected for the study. This was a self-reported diagnosis, as the respondent was specifically asked, "do you have epilepsy?" with the four possible answers being "yes," "no," "don't know," or "refuse to answer." The validity of self-reported epilepsy in population-based surveys has been evaluated and demonstrated to have high sensitivity (84%) and specificity (99%) that compare favorably to other chronic conditions. 16, 17 The sample was then restricted to those with active epilepsy defined as "currently taking medication for epilepsy" and/or "had a seizure in the past 5 years" (N = 713). Additional epilepsy-specific variables included age at diagnosis and first symptoms, change in condition compared to when diagnosed, and reason(s) for improvement in epilepsy.
Study variables
We explored the associations between a wide array of variables and active epilepsy in this study. These study variables are described below.
Sociodemographic variables including age, sex, highest level of education achieved, work status in the past week,
Key Points
• Most published studies examining epilepsy outcomes by seizure status are from specialized clinics, detracting from the external validity of existing literature
• When controlling for age and sex, there is no difference in heart disease, hypertension, and diabetes between those with and without active epilepsy
• Even one seizure over five years was associated with greater self-reported mood disorders compared to seizure-free patients • Even one seizure over 5 years was associated with poorer stigma outcomes and lower education/employment compared to seizure-free patients
• Even one seizure over 5 years was associated with worse daily activity outcomes compared to seizurefree patients and work activities in past 3 months were assessed using standard field-tested items.
Long-term chronic conditions (heart condition, high blood pressure, diabetes, and mood disorders, i.e., depression, bipolar disorder, or dysthymia) were included in the analysis. These self-reported chronic conditions were defined as "long term conditions which are expected to last or have already lasted 6 months or more and that have been diagnosed by a health professional." The accuracy of selfreported diabetes and hypertension has been validated through previous analyses. 18 The Patient Health Questionnaire-9 (PHQ-9) was included as a validated measure of depressive symptoms. 19 The PHQ-9 is a depression assessment scale for screening, monitoring, and measuring severity during the previous 2 weeks, which has been validated in epilepsy. 19 The scale parallels the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (and Fifth Edition, DSM-5) definition of major depressive episode by assessing nine symptoms corresponding with the symptom-based DSM criteria for major depressive episode. PHQ-9 scores range from 0 to 27, with higher scores indicating more severe depression. The PHQ-9 is often analyzed using a cutpoint of 10, with scores above this point corresponding to moderate to severe depression. 19, 20 Respondents were asked to rate their overall general health and amount of life stress for most days on 5-point scales. Self-perceived general health ranged from "excellent" to "poor," whereas life stress ranged from "not at all stressful" to "extremely stressful."
The Health Utility Index Mark 3 (HUI3) was included as a measure of overall functional health. 21 The index assesses health status and quality of life in eight domains (hearing, vision, speech, mobility, dexterity, emotion, cognition, and pain). Each domain is assessed with five to six levels. Combined with a set of utility weights, the index is designed to produce both an overall health utility score and eight individual attribute scores. Overall scores can range from 1.00 (perfect health) to À0.36 (health status worse than death: a score of 0 indicates a health state preference equivalent to death). The current study used the overall score as both a continuous variable and a categorical variable (dichotomized at the accepted cut point of 0.7). A score of <0.7 equates to severe disability. 22 Two SLNCC modules examined formal and informal assistance received at home, work, or school in the previous 12 months because of the neurologic condition. Questions included in this study addressed if assistance was received, the frequency of assistance, the type of assistance, and the person providing assistance. These modules were field tested by Statistics Canada.
Restriction of activities included whether the respondent's neurologic condition limited their usual activities including education, job, sleep, and overall life. Each was measured on a 5-point scale (not at all, a little bit, moderately, quite a bit, and extremely). The variables were analyzed using the five original categories and two categories (not at all vs. a little bit/moderately/quite a bit/extremely). Two variables related to driving (among those at least 16 years of age) were also included in the analysis: (1) having a valid driver's license and (2) ever prevented from driving or ever prevented from having a driver's license because of epilepsy.
Four questions addressed feelings and perceptions in relation to stigma: (1) "some people seemed uncomfortable with me," (2)"some people avoided me," (3)"felt left out of things," and (4)"felt embarrassed about my epilepsy." Respondents rated each item on a 5-point scale ranging from "never" to "always." To create a binary variable reflecting the experience of stigmatization, each variable was dichotomized as "never" versus "rarely, sometimes, often, or always."
Analysis
Overall active epilepsy (seizure within the past 5 years or taking a medication) and seizure-specific (no seizure vs. seizure group) weighted proportions and means, along with associated 95% confidence intervals (CIs) were calculated for each of the study variables described earlier.
For example, mean age was calculated for those with active epilepsy (overall), for those who did not have a seizure in the past 5 years, and for those who had a seizure in the past 5 years. Similarly, the three groups were stratified by the variables described. Five years was chosen as a conservative measure, since ongoing seizures over a 5-year period is considered consistent with active epilepsy by many authorities, especially for studies in high-income countries. 23 Ordinal logistic regression models and logistic models were employed to assess the associations between and the study variables and seizure status. Patient self-perceived general health and self-perceived life stress (ranked from 1 to 5 as described above) were included in ordinal regression analyses. The remaining 17 binary outcomes (e.g., depression, HUI, restriction of activities, stigma) were examined with logistic regression models. The following seven models were used to evaluate each outcome: (1) unadjusted, (2) sex adjusted, (3) age adjusted, (4) sex and age adjusted, (5) sex and sex by seizure interaction, (6) age and age by seizure interaction, and (7) all-inclusive model.
As recommended by Statistics Canada, 500 replicate bootstrap weights are applied to ensure that the standard errors are accurate and to account for the complex sampling strategy.
14 These weights also contained poststratification demographic adjustments and adjustment for nonresponse. All data analysis was conducted at the Statistics Canada Regional Data Centre using STATA 14. 24 Under regulatory framework governing the use of these datasets, approval by an Ethics Review Board is not required.
Results
The overall prevalence of active epilepsy in the CCHS cohort was 0.4% (95% CI 0.36-0.44%). In the SLNCC cohort, we identified 713 patients with active epilepsy, of whom 95.7% were taking at least one antiepileptic drug and 297 (42%) were seizure-free over the prior 5 years. These 297 patients were considered to have self-reported epilepsy that was in remission. Four patients were excluded from the stratified analyses, since no information was available regarding their seizure status over the previous 5 years. Demographic Table 1 ).
Epilepsy-specific factors
Compared to when initially diagnosed, 53.4% (95% CI 46.0-60.8%) of the total cohort felt that their epilepsy was much better, whereas 27.4% (95% CI 19.5-35.4%) felt that it was somewhat better. A total of 19.2% (95% CI 13.7-24.7%) felt that it was about the same/somewhat worse/ much worse. The majority of those in seizure remission indicated their epilepsy was much better than at the point of diagnosis (70.1%; 95% CI 60.6-79.7%) compared to less than half (42.7%; 95% CI 33.3-52.1%) who had active seizures. Most people who felt that their epilepsy was improved attributed it to medications, irrespective of whether they had active seizures (86.2%; 95% CI 76.0-96.5%) or had seizures in remission (97.3%; 95% CI 95.2-99.4%). Similar proportions indicated that their epilepsy was improved due to surgery (overall cohort: 4.8%, 95% CI 2.7-6.9%; active seizures: 5.5%, 95% CI 2.6-8.5%; seizures in remission: 4.0%, 95% CI 1.0-6.9%).
Comorbidities
Proportions with cardiovascular disease and diabetes did not vary significantly according to seizure status when controlling for age and sex (Table 2) . Self-reported mood disorders (ascertained by asking "Do you have a mood disorder such as depression, bipolar disorder, mania, or dysthymia?") were more common in those with ongoing seizures (20.4%; 95% CI 13.5-27.3%) compared to those who were 5-years seizure-free (12%; 95% CI 5.8-18.1%; p < 0.001).
Of those with seizures, 32.1% (95% CI 18.8-45.3) had symptoms suggestive of major depression, compared to 7.7% (95% CI 3.4-11.9; p < 0.001) of those without seizures based on the PHQ-9. The odds of depression, using a cut-off point of 10 on the PHQ-9 scale, were 6.4-fold higher (95% CI 2.6-16.3; p < 0.001) in those with at least one seizure in the past 5 years when controlling for age and sex.
Health perceptions and social outcomes
The sex-and age-adjusted odds of considering one's health to be excellent (as opposed to poor to very good) were 2.5-fold higher (95% CI 1.5-4.1; p < 0.001) if patients were seizure-free over the prior 5 years when controlling for age and sex. Likewise, the odds of poorer health when measured using the HUI, was 3.0-fold higher (95% CI 1.6-5.7) for those with active epilepsy when using a cut-off score of <0.7 and controlling for age and sex. Self-perceived stress was not significantly influenced by seizure status when controlling for age and sex (odds ratio [OR] 1.5, 95% CI 1.0-2.5; p = 0.071).
Although the need for daily professional hired assistance was not significantly elevated according to seizure status (OR 1.4, 95% CI 0.7-2.9; p = 0.395), the need for daily informal assistance (provided for by family and/or friends) was significantly elevated in those with ongoing seizures over the past 5 years when controlling for age and sex (OR 4.0, 95% CI 2.0-7.8; p < 0.001). As expected, those with at least one seizure in the past 5 years had 4.5-fold odds of being prevented from driving (95% 2.5-8.2; p < 0.001) compared to those who were seizure-free.
In addition, ongoing seizures negatively influenced educational and vocational opportunities. The odds of having limitations to education, employment, and activities of daily living were all increased in those with seizures over the past 5 years. Likewise, seizure status had a significant impact on how much epilepsy affected a patient's overall life and the overall stigma faced by individuals (Table 3) .
Discussion
This national study demonstrates that seizure status is associated with clinical and psychosocial outcomes. The majority of patients felt that they had experienced improvements in their epilepsy since their time of diagnosis. Much of this improvement was attributed to medication effect. However, despite this, patients with ongoing seizures over the 5 years prior to contact had higher odds of depression, lower perceptions of their general health, lower objective measurements of functional health, and poorer social outcomes, which included limitations in education and work, and greater exposure to stigma.
These results emphasize the importance of achieving seizure freedom in patients with epilepsy. Although we are unable to substratify the active epilepsy group into those with at least one seizure over the past year (vs. those with at least one seizure in the past 5 years), the definition we use conforms to the International League Against Epilepsy (ILAE) Epidemiology Commission Report's recommendations for "active" epilepsy in epidemiologic studies (current use of AEDs or the last seizure occurring within 2-5 years of the study enrollment). 23 Furthermore, although those failing to achieve seizure freedom over 1 year may disproportionately drive the propensity for worse physical and psychosocial outcomes in the active epilepsy group, it is important to note that our results still remain robust despite including patients with only one seizure over 5 years (who would be expected to dilute the magnitude of the overall results).
Implicit in our conclusions is that early referral to an epilepsy specialist center for those with drug-resistant epilepsy may improve overall health. This is predicated on the fact that those who were seizure-free over the prior 5 years almost invariably benefited in all measures of clinical and psychosocial outcomes. Alternatively, seizures, even if improved with medication or surgery, likely continue to exert negative effects on a patient's well-being, as long as they persist at a frequency of even one seizure over the prior 5 years of contact. This is consistent with prior findings in a pediatric population wherein even those children with a single seizure had a reduction in their quality of life compared to those without a history of epilepsy. 25 This is most likely related to the fact that ongoing seizures have direct repercussions on a patient's ability to drive and work, which contributes to lowered subjective and objective measurements of quality of life. 26 Furthermore, our results suggest that ongoing seizures may directly contribute to the stigma faced by patients with epilepsy. Complete seizure freedom should therefore be the aim for all patients.
In addition, our results support the importance of community-based programs designed to enhance quality of life, social, and psychological outcomes while addressing the evident stigma faced by those with epilepsy. Unfortunately, limited data exist to inform the development and ideal organizational structure of this type of intervention for epilepsy. This represents a critical gap in knowledge, as those with active epilepsy in this community-based sample were found to have higher rates of depression (32.1% vs. 7.7%), lower levels of education with perceived limitations in education received (50.9% vs. 32.2%), and limitations in employment (66.2% vs. 38.7%), sleep (50.8% vs. 27.3%), life (81.1% vs. 54%), and usual everyday activities (92.7% vs. 74.9%). Furthermore, the odds of experiencing stigma were 2.1-to 4.1-fold higher (according to the type of stigma; Table 3 ) for those with active epilepsy. This further emphasizes the need for prioritizing interventions for those with medicationresistant epilepsy. Not all patients can be seen in a tertiary care center, and, ideally, in an epilepsy monitoring unit in a timely fashion. Hence, community-based support systems are critical for augmenting health in what is clearly a vulnerable patient population even in community settings.
This study benefits from the population-based nature of the cross-sectional survey. The CCHS collects data related to health status, healthcare utilization, and determinants of health on a subprovincial level in Canada. It uses a large sample of respondents to draw reliable and precise estimates of health. The SLNCC was initiated with the goal of filling gaps in knowledge about individuals with neurologic conditions, and their families and caregivers. This is a cross-sectional survey of 8,200 patients covering 18 neurologic conditions that derived its sample population from the CCHS. Expert groups, including delegates from the Public Health Agency of Canada, Statistics Canada, and the Neurological Health Charities of Canada, met to provide consensus measures for each specific disease including epilepsy. Control and monitoring measures, including response rate evaluation, reported and nonreported data evaluation, outof-scope patient evaluation, on-site observation of interviews, and improved collection tools were implemented throughout the entire process to ensure optimal data acquisition and to minimize nonsampling errors. Comparisons to data collected by the CCHS over the prior year were performed to ensure consistency. Likewise, rigorous evaluation of data by analysts to identify missing or erroneous values, and external validation by consultation with Provincial and Federal authorities to identify any concerns or anomalies with the data, were used to enhance confidence and internal validity. Finally, the sample size is large enough to limit the impact of random error. There are some potential limitations to the study. Although the estimated response rate was 81.6%, systematic biases cannot be entirely excluded. Sampling errors are possible due to response bias. However, our high response rate enhances precision, and, although the overall percentage itself is not always a reliable indicator of nonresponse bias, 27 it is unlikely that this bias would be significant as over 80% agreed to participate. There was minimal partial nonresponse bias (where only part of the questionnaire was completed), and nonresponse was controlled through adjustments made to the weights of persons who responded to the Active seizures are defined as at least one seizure in the past 5 years. The odds presented are of worse education, employment, and indices of activities of daily life in those with at least one seizure over the prior 5 years (compared to those in seizure remission) using logistic regression controlling for age and sex. survey. The self-reported nature of the conditions in the study could contribute to nondifferential misclassification bias. However, the relative accuracy of self-reported conditions such as epilepsy 16 and heart disease 18 relative to administrative data and medical records has been validated and determined to be comparable. This form of misclassification bias would be expected to dilute the overall point estimate of each outcome. However, the possibility of differential misclassification bias also exists. A limitation to the questionnaire is that the person is only asked if they have been diagnosed with "epilepsy," so we may have missed individuals who consider themselves to have a "seizure disorder" rather that epilepsy. This would result in an erroneously low estimate of the prevalence of active epilepsy and spuriously dilute overall estimates, since the "control" group would inadvertently contain patients with active epilepsy. It is anticipated, though, that this would constitute a minority of patients recruited into the SLNCC study. We were not able to acquire detailed estimates of seizure frequency so therefore made the a priori decision to stratify groups into those with no seizures over the past 5 years prior to contact (epilepsy remission) and those with at least one seizure in the past 5 years (active epilepsy). This was a conservative decision that was made to minimize the impact of misclassification bias. In the worst-case scenario, misclassification due to difficulties recalling a seizure over the prior 5 years would lead to inadvertent inclusion of more active epilepsy patients in the remission group, thus again leading to a diluted point estimates. Due to the cross-sectional nature of the study, causal inferences cannot be directly supported. In addition, the dataset did not provide comprehensive coverage of comorbidities such as gastrointestinal and respiratory conditions. Finally, we could not account for the presence of concurrent conditions, such as static epileptic encephalopathies, traumatic brain injury, and stroke, which could have contributed to higher estimates of lower education and unemployment in the active seizure population. However, although inclusion of these patients could elevate the estimates for these socioeconomic outcomes, we only sampled noninstitutionalized individuals, thereby partially mitigating this risk, as more severe cases would be automatically excluded.
These analyses are the first to describe the national impact of seizures at a community level in Canada. As a developed nation, these results are expected to have strong external validity with countries that comprise a similar demographic makeup. The results clearly indicate that, in this setting, seizure status exerts a major influence on the overall well-being of the patient. Those who achieved 5-year seizure remission reported better health and psychosocial outcomes on almost every scale. This adds additional weight to the argument that striving for complete seizure freedom in all patients in paramount. Furthermore, these results emphasize that even on a community-based population level, those with epilepsy and, in particular, active epilepsy, are exposed to major psychological and socioeconomic barriers to healthy living. Thus, communitybased interventions existing outside the auspices of tertiary care centers are critically needed to narrow this treatment gap.
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